XML 86 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
Collaborative Research, Development and License Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 5 Months Ended 12 Months Ended
Aug. 31, 2023
Apr. 30, 2023
Sep. 30, 2021
Aug. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jul. 31, 2023
Apr. 27, 2023
Apr. 26, 2023
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Collaborative arrangement and arrangement other than collaborative, term         2 years          
Advance Payments forgiven per CEPI-Bio E Assignment Agreement (Note 9)         $ 0 $ (47,401) $ 0      
Repayment of advance from customer                 $ 47,400  
Accrued liabilities (Note 7)         61,066 49,448        
Total revenues         277,246 232,284 $ 722,683      
Allowance for doubtful accounts receivables         12,313 12,313        
U.S. Department of Defense                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Government assistance, transaction duration     2 years 6 months              
Government assistance, award amount         30,000     $ 33,700    
Coalition for Epidemic Preparedness Innovations                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Accounts receivable                 $ 47,400  
CEPI Partners                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Advance Payments forgiven per CEPI-Bio E Assignment Agreement (Note 9)         175,000          
Repayment of advance from customer         67,300          
Accrued liabilities (Note 7)         47,400          
Accrual long-term balance         60,300          
Long-term deferred revenue         0 0        
Zhejiang Clover Biopharmaceuticals Inc And Clover Hong Kong Inc                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Accrual long-term balance         60,300          
Zhejiang Clover Biopharmaceuticals Inc And Clover Hong Kong Inc | Supply Agreement                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Contract asset balance           71,300        
Biological E. Limited                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Repayment of advance from customer                   $ 47,400
Prepayment of advance payment $ 1,000 $ 13,500   $ 14,500            
Additional future payment                   5,500
Biological E. Limited | Term 1                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Advance payment received                   125,000
Biological E. Limited | Term 2                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Additional future payment                   12,300
Advance payment received                   $ 250,000
U.S. Department of Defense                    
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                    
Total revenues         $ 8,600 $ 17,600        
Proceeds from grant     $ 22,000